Dear NYS COVID-19 Vaccine Provider: On January 4, 2022, the CDC updated the recommendation for receipt of a booster dose of the COVID-19 vaccine following receipt of the Pfizer-BioNTech primary series. CDC now recommends receipt of a booster dose at least five months after completing their Pfizer-BioNTech primary series. This previously refcommended interval was at least
Important COVID-19 Vaccination Program Guidance Dear NYS COVID-19 Vaccine Provider: On November 29, 2021, the CDC strengthened its recommendation on booster doses to indicate that everyone 18 years of age and older should get a booster shot either 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine. Attached is revised Guidance for
Statement from Governor Kathy Hochul on COVID-19 Boosters "As Governor, I am committed to protecting the health and safety of all New Yorkers, and with the holidays coming up, we must continue to do everything we can to keep New Yorkers safe and prevent the spread of COVID-19. "We know the vaccine not only
Important COVID Vaccination Program Guidance - Vaccination of Children Ages 5-11 Please see the attached Guidance for the New York State COVID-19 Vaccination Program: Vaccination of Children Ages 5-11; Information for Health Care Professionals about the Screening Checklist for the Administration of Pfizer-BioNTech COVID-19 Vaccine for Children 5-11 years old; and COVID-19 Immunization Screening and Consent Form: Children and Adolescents Ages
Important COVID Vaccination Program Guidance (Oct. 25, 2021) The attached information was sent to all providers enrolled in the NYS COVID-19 vaccination program. It is updated to reflect the FDA authorization and CDC approval of Moderna and J&J booster doses for eligible individuals and the administration of heterologous booster doses. Included are: The attached Guidance for The
Dear COVID-19 Vaccination Provider: On September 24, 2021, under the U.S. Food and Drug Administration’s (FDA) updated emergency use authorization (EUA), the CDC issued recommendations for a single dose of the Pfizer-BioNTech COVID-19 Vaccine at least six months after completion of the primary series for the following individuals: individuals 65 years of age and older, and
Pfizer-BioNTech COVID-19 Vaccine Licensure and Expiration Extension Dear COVID-19 Vaccination Provider, The FDA granted full licensure for Pfizer's COVID-19 vaccine on August 23, 2021. The full licensure applies to the use of this vaccine in the 16+ population. The vaccine also continues to be available under emergency use authorization (EUA) for adolescents 12 through 15 years of age and
Janssen/Johnson & Johnson COVID-19 Vaccine Expiration Extension On July 29, 2021, the U.S. Food & Drug Administration (FDA) authorized an extension of the shelf life for the Janssen/Johnson & Johnson (J&J) single-shot COVID-19 vaccine by 45 days, from 4.5 months to 6 months. The decision is based on data from ongoing stability assessment studies, which have
Important Information regarding Janssen/Johnson & Johnson (J&J) COVID-19 Vaccine On July 13, 2021, the U.S. Food and Drug Administration (FDA) announced revisions to the Emergency Use Authorization (EUA) fact sheets for the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine to include information regarding an observed increased risk of Guillain-Barre Syndrome (GBS) after administration of the vaccine.
Dear COVID-19 Vaccination Program Provider: This message is being sent to all COVID-19 Vaccination Program enrolled providers in an effort to increase vaccinated individuals’ ability to obtain an Excelsior Pass. If you have not yet administered COVID-19 vaccine, you may disregard this message. Excelsior Pass mobile application is New York State’s voluntary and secure way
